Livermore

DME Capital Management, LP

Superinvestor

Greenlight Capital

SEC CIK
0001489933
Manager
David Einhorn
Style
Value, Hedge fund

Previously filed asGREENLIGHT CAPITAL INC

GANX holding history

Gain Therapeutics, Inc.

Every 13F filing in which Greenlight Capital reported holding GANX, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.

GANX overviewAll 13F holders of GANXFull portfolio

DME Capital Management, LP: GANX holding by quarter
QuarterSharesValue% of portfolioChange in sharesAction
Q2 2026566,130$1.15M0.03%00.0%Unchanged
Q1 2026566,130$1.1M0.03%00.0%Unchanged
Q4 2025566,130$1.82M0.06%00.0%Unchanged
Q3 2025566,130$1M0.04%00.0%Unchanged
Q2 2025566,130$1.02M0.04%00.0%Unchanged
Q1 2025566,130$1.08M0.05%00.0%Unchanged
Q4 2024566,130$1.22M0.06%00.0%Unchanged
Q3 2024566,130$1.01M0.04%00.0%Unchanged
Q2 2024566,130$724.65K0.04%00.0%Unchanged
Q1 2024566,130$2.13M0.10%+566,130New